# Phase I study of amatuximab, a novel monoclonal antibody to mesothelin, in Japanese patients with advanced solid tumors

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-i-study-of-amatuximab-a-novel-monoclonal-antibody-to-mesothelin-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yasuhito Fujisaka,Takayasu Kurata,Kaoru Tanaka,Toshihiro Kudo,Kunio Okamoto,Junji Tsurutani,Hiroyasu Kaneda,Isamu Okamoto,Masayuki Namiki,Chifumi Kitamura,Kazuhiko Nakagawa |
| Citations | 53 |
| DOI | 10.1007/s10637-014-0196-0 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s10637-014-0196-0.pdf |
| OpenAlex ID | https://openalex.org/W2069723223 |
| PMID | 25502863 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Kunio Okamoto](https://scholariq.org/researchers/kunio-okamoto/)

## Paper journal

- [Investigational New Drugs](https://scholariq.org/journals/investigational-new-drugs/)

## Paper primary topic

- [Occupational and environmental lung diseases](https://scholariq.org/topics/occupational-and-environmental-lung-diseases/)

## Paper topics

- [Occupational and environmental lung diseases](https://scholariq.org/topics/occupational-and-environmental-lung-diseases/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.